Determinants of Survival After Emergency Intrapericardial Cisplatin Treatment in Cancer Patients with Recurrent Hemodynamic Instability After Pericardiocentesis
Publication
, Journal Article
Published in: In Vivo
February 27, 2018
Duke Scholars
Published In
In Vivo
DOI
EISSN
1791-7549
Publication Date
February 27, 2018
Volume
32
Issue
2
Publisher
International Institute of Anticancer Research
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3203 Dentistry
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Determinants of Survival After Emergency Intrapericardial Cisplatin Treatment in Cancer Patients with Recurrent Hemodynamic Instability After Pericardiocentesis. (2018). In Vivo, 32(2). https://doi.org/10.21873/invivo.11248
“Determinants of Survival After Emergency Intrapericardial Cisplatin Treatment in Cancer Patients with Recurrent Hemodynamic Instability After Pericardiocentesis.” In Vivo 32, no. 2 (February 27, 2018). https://doi.org/10.21873/invivo.11248.
“Determinants of Survival After Emergency Intrapericardial Cisplatin Treatment in Cancer Patients with Recurrent Hemodynamic Instability After Pericardiocentesis.” In Vivo, vol. 32, no. 2, International Institute of Anticancer Research, Feb. 2018. Crossref, doi:10.21873/invivo.11248.
Determinants of Survival After Emergency Intrapericardial Cisplatin Treatment in Cancer Patients with Recurrent Hemodynamic Instability After Pericardiocentesis. In Vivo. International Institute of Anticancer Research; 2018 Feb 27;32(2).
Published In
In Vivo
DOI
EISSN
1791-7549
Publication Date
February 27, 2018
Volume
32
Issue
2
Publisher
International Institute of Anticancer Research
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3203 Dentistry
- 3202 Clinical sciences
- 1103 Clinical Sciences